KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ginkgo Bioworks Holdings (DNA) Receivables - Other (2020 - 2025)

Historic Receivables - Other for Ginkgo Bioworks Holdings (DNA) over the last 6 years, with Q3 2025 value amounting to $11.2 million.

  • Ginkgo Bioworks Holdings' Receivables - Other rose 3827.16% to $11.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $11.2 million, marking a year-over-year increase of 3827.16%. This contributed to the annual value of $11.3 million for FY2024, which is 63091.85% up from last year.
  • As of Q3 2025, Ginkgo Bioworks Holdings' Receivables - Other stood at $11.2 million, which was up 3827.16% from $10.9 million recorded in Q2 2025.
  • In the past 5 years, Ginkgo Bioworks Holdings' Receivables - Other ranged from a high of $11.3 million in Q4 2024 and a low of $300000.0 during Q2 2021
  • For the 5-year period, Ginkgo Bioworks Holdings' Receivables - Other averaged around $7.0 million, with its median value being $7.1 million (2022).
  • In the last 5 years, Ginkgo Bioworks Holdings' Receivables - Other crashed by 1178.05% in 2021 and then surged by 98433.33% in 2022.
  • Over the past 5 years, Ginkgo Bioworks Holdings' Receivables - Other (Quarter) stood at $4.6 million in 2021, then skyrocketed by 34.34% to $6.2 million in 2022, then soared by 63.51% to $10.1 million in 2023, then increased by 11.88% to $11.3 million in 2024, then dropped by 0.88% to $11.2 million in 2025.
  • Its Receivables - Other was $11.2 million in Q3 2025, compared to $10.9 million in Q2 2025 and $11.3 million in Q4 2024.